Atlas Trials

Relapsed or Refractory Acute Myeloid Leukemia

15 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Relapsed or Refractory Acute Myeloid Leukemia

RecordFirmDate
Clinical Study of Mitoxantrone Hydrochloride Liposome Injection in Subjects With Acute Myeloid Leukemia (NCT05522192)Hui Zeng2022-07-21
A Study to Evaluate MK-0482 for Relapsed/Refractory Acute Myeloid Leukemia (AML) or Chronic Myelomonocytic Leukemia (CMML) (MK-0482-002) (NCT05038800)Merck Sharp & Dohme LLC2021-09-26
Pegcrisantaspase in Combination With Venetoclax for Treatment of Relapsed or Refractory Acute Myeloid Leukemia (R/R AML) (NCT04666649)University of Maryland, Baltimore2021-03-10
Study of AMG 330 in Combination With Pembrolizumab in Adult With Relapsed or Refractory Acute Myeloid Leukemia (NCT04478695)Amgen2020-09-29
Evaluation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PHI 101 for the Treatment of AML (NCT04842370)Seoul National University Hospital2020-06-08
Dexamethasone in Refractory or First Relapsed Acute Myeloid Leukemia (NCT03765541)University Hospital, Toulouse2020-01-13
A China Bridging Study of Ivosidenib in r/r AML Subjects With an IDH1 Mutation (NCT04176393)CStone Pharmaceuticals2019-11-12
Study of a New Intravenous Drug, Called S65487, in Patients With Acute Myeloid Leukemia, Non Hodgkin Lymphoma, Multiple Myeloma or Chronic Lymphocytic Leukemia (NCT03755154)Institut de Recherches Internationales Servier2019-07-17
AMG 176 First in Human Trial in Participants With Relapsed or Refractory Multiple Myeloma and Participants With Relapsed or Refractory Acute Myeloid Leukemia (NCT02675452)Amgen2016-06-13
CD123 Redirected Autologous T Cells for AML (NCT02623582)University of Pennsylvania2015-12-01
Dose Escalation Study in Acute Myeloid or B-Cell Acute Lymphoblastic Leukemia (NCT02215629)Verastem, Inc.

Track Relapsed or Refractory Acute Myeloid Leukemia automatically

Every clearance here is in the API, with alerts when new ones post.